These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12707994)

  • 21. Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury.
    Tanaka T; Noiri E; Yamamoto T; Sugaya T; Negishi K; Maeda R; Nakamura K; Portilla D; Goto M; Fujita T
    Nephron Exp Nephrol; 2008; 108(1):e19-26. PubMed ID: 18182783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease.
    Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Inoue T; Node K
    Am J Nephrol; 2006; 26(1):82-6. PubMed ID: 16534182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs.
    Takashima S; Nagamori Y; Ohata K; Oikawa T; Sugaya T; Kobatake Y; Nishii N
    J Vet Med Sci; 2021 Sep; 83(9):1465-1471. PubMed ID: 34526412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
    Nakamura T; Sugaya T; Node K; Ueda Y; Koide H
    Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.
    Manabe K; Kamihata H; Motohiro M; Senoo T; Yoshida S; Iwasaka T
    Eur J Clin Invest; 2012 May; 42(5):557-63. PubMed ID: 22070248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel.
    Gollin G; Marks C; Marks WH
    Surgery; 1993 May; 113(5):545-51. PubMed ID: 8488474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.
    Kamijo-Ikemori A; Sugaya T; Matsui K; Yokoyama T; Kimura K
    Nephrology (Carlton); 2011 Aug; 16(6):539-44. PubMed ID: 21504508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between exercise capacity and urinary liver-type fatty acid-binding protein in middle-aged and older individuals.
    Kosaki K; Kamijo-Ikemori A; Sugaya T; Tanahashi K; Kumagai H; Sawano Y; Akazawa N; Ra SG; Kimura K; Shibagaki Y; Maeda S
    Clin Exp Nephrol; 2017 Oct; 21(5):810-817. PubMed ID: 28197733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary Liver Type Fatty Acid Binding Protein Is Negatively Associated With Estimated Glomerular Filtration Rate in Renal Transplant Recipients With Graft Loss.
    Huang YC; Chang YS; Chen CC; Tsai SF; Yu TM; Wu MJ; Chen CH
    Transplant Proc; 2018 May; 50(4):1083-1086. PubMed ID: 29731071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid-binding protein as marker for renal injury.
    Pelsers MM
    Scand J Clin Lab Invest Suppl; 2008; 241():73-7. PubMed ID: 18569970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis.
    Torigoe K; Muta K; Tsuji K; Yamashita A; Ota Y; Kitamura M; Mukae H; Nishino T
    Med Sci Monit; 2020 Dec; 26():e928236. PubMed ID: 33347426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndrome.
    Matsumori R; Shimada K; Kiyanagi T; Hiki M; Fukao K; Hirose K; Ohsaka H; Miyazaki T; Kume A; Yamada A; Takagi A; Ohmura H; Miyauchi K; Daida H
    J Cardiol; 2012 Sep; 60(3):168-73. PubMed ID: 22658694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Possibility of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker of Renal Hypoxia in Spontaneously Diabetic Torii Fatty Rats.
    Tanabe J; Ogura Y; Nakabayashi M; Nagai Y; Watanabe S; Sugaya T; Ohata K; Ichikawa D; Inoue K; Hoshino S; Kimura K; Shibagaki Y; Ono Y; Kamijo-Ikemori A
    Kidney Blood Press Res; 2019; 44(6):1476-1492. PubMed ID: 31734667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 435-bp liver regulatory sequence in the liver fatty acid binding protein (L-FABP) gene is sufficient to modulate liver regional expression in transgenic zebrafish.
    Her GM; Yeh YH; Wu JL
    Dev Dyn; 2003 Jul; 227(3):347-56. PubMed ID: 12815620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary liver-type fatty acid-binding protein as a prognostic marker in patients with acute heart failure.
    Sunayama T; Yatsu S; Matsue Y; Dotare T; Maeda D; Ishiwata S; Nakamura Y; Suda S; Kato T; Hiki M; Kasai T; Minamino T
    ESC Heart Fail; 2022 Feb; 9(1):442-449. PubMed ID: 34921522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between Urinary Liver-Type Fatty Acid-Binding Protein (L-FABP) and Sarcopenia in Spontaneously Diabetic Torii Fatty Rats.
    Tanabe J; Ogura Y; Kosaki K; Nagai Y; Sugaya T; Ohata K; Watanabe S; Ichikawa D; Inoue K; Hoshino S; Kimura K; Maeda S; Shibagaki Y; Kamijo-Ikemori A
    J Diabetes Res; 2020; 2020():7614035. PubMed ID: 32405506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation.
    Jolly CA; Hubbell T; Behnke WD; Schroeder F
    Arch Biochem Biophys; 1997 May; 341(1):112-21. PubMed ID: 9143360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty acid transfer across the myocardial capillary wall: no evidence of a substantial role for cytoplasmic fatty acid-binding protein.
    Van Nieuwenhoven FA; Verstijnen CP; Van Eys GJ; Van Breda E; De Jong YF; Van der Vusse GJ; Glatz JF
    J Mol Cell Cardiol; 1994 Dec; 26(12):1635-47. PubMed ID: 7731058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas.
    Celis JE; Ostergaard M; Basse B; Celis A; Lauridsen JB; Ratz GP; Andersen I; Hein B; Wolf H; Orntoft TF; Rasmussen HH
    Cancer Res; 1996 Oct; 56(20):4782-90. PubMed ID: 8840999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle.
    Glatz JF; Schaap FG; Binas B; Bonen A; van der Vusse GJ; Luiken JJ
    Acta Physiol Scand; 2003 Aug; 178(4):367-71. PubMed ID: 12864741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.